Coronary microcirculation and left ventricular diastolic function: comparison between patients on hemodialysis and peritoneal dialysis.
Coronary flow reserve
Diastolic dysfunction
Echocardiography
Hemodialysis
Peritoneal dialysis
Journal
Journal of echocardiography
ISSN: 1880-344X
Titre abrégé: J Echocardiogr
Pays: Japan
ID NLM: 101263153
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
16
06
2020
accepted:
16
09
2020
revised:
31
08
2020
pubmed:
27
9
2020
medline:
29
10
2021
entrez:
26
9
2020
Statut:
ppublish
Résumé
End-stage renal disease is considered to influence coronary microcirculation and left ventricular (LV) diastolic function. We investigated whether differences exist in LV diastolic function indices and coronary flow reserve (CFR) between patients on hemodialysis (HD) and peritoneal dialysis (PD). A complete transthoracic echocardiographic study was performed on 21 HD and 22 PD patients and LV diastolic function was evaluated. CFR was estimated using transthoracic Doppler echocardiography on the left anterior descending artery, during high-dose dypiridamole infusion. HD and PD groups did not differ regarding Doppler-derived diastolic indices, but they significantly differed in the frequency of severe LV hypertrophy (38.1% in HD vs 4.5% in PD group, p = 0.009) and grade II diastolic dysfunction (42.9% in HD vs 4.5% in PD group, p = 0.004). No patient had restrictive filling pattern. There was no difference in the prevalence of arterial hypertension and diabetes mellitus in patients with grade II vs less than grade II dysfunction. Mean CFR was similar in the HD and PD groups (2.25 ± 0.65 vs 2.36 ± 0.76, p = 0.635) and lower in patients with grade II diastolic dysfunction (1.87 ± 0.43 vs 2.44 ± 0.72, p = 0.023) and diabetes (1.70 ± 0.59 vs 2.39 ± 0.68, p = 0.04). LV mass index was negatively associated with CFR (r = - 0.308, p = 0.045). Patients on HD had more advanced diastolic dysfunction compared to PD, independently of the presence of hypertension and diabetes. CFR did not differ between HD and PD patients, but it was significantly lower in diabetics and in patients with more advanced diastolic dysfunction.
Sections du résumé
BACKGROUND
End-stage renal disease is considered to influence coronary microcirculation and left ventricular (LV) diastolic function. We investigated whether differences exist in LV diastolic function indices and coronary flow reserve (CFR) between patients on hemodialysis (HD) and peritoneal dialysis (PD).
METHODS
A complete transthoracic echocardiographic study was performed on 21 HD and 22 PD patients and LV diastolic function was evaluated. CFR was estimated using transthoracic Doppler echocardiography on the left anterior descending artery, during high-dose dypiridamole infusion.
RESULTS
HD and PD groups did not differ regarding Doppler-derived diastolic indices, but they significantly differed in the frequency of severe LV hypertrophy (38.1% in HD vs 4.5% in PD group, p = 0.009) and grade II diastolic dysfunction (42.9% in HD vs 4.5% in PD group, p = 0.004). No patient had restrictive filling pattern. There was no difference in the prevalence of arterial hypertension and diabetes mellitus in patients with grade II vs less than grade II dysfunction. Mean CFR was similar in the HD and PD groups (2.25 ± 0.65 vs 2.36 ± 0.76, p = 0.635) and lower in patients with grade II diastolic dysfunction (1.87 ± 0.43 vs 2.44 ± 0.72, p = 0.023) and diabetes (1.70 ± 0.59 vs 2.39 ± 0.68, p = 0.04). LV mass index was negatively associated with CFR (r = - 0.308, p = 0.045).
CONCLUSION
Patients on HD had more advanced diastolic dysfunction compared to PD, independently of the presence of hypertension and diabetes. CFR did not differ between HD and PD patients, but it was significantly lower in diabetics and in patients with more advanced diastolic dysfunction.
Identifiants
pubmed: 32979192
doi: 10.1007/s12574-020-00493-7
pii: 10.1007/s12574-020-00493-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
103-112Références
Antlanger M, Aschauer S, Kopecky C, et al. Heart Failure with preserved and reduced ejection fraction in hemodialysis patients: prevalence, disease prediction and prognosis. Kidney Blood Press Res. 2017;42(1):165–76.
pubmed: 28395286
Wu CK, Lee JK, Wu YF, et al. Left ventricular diastolic dysfunction in peritoneal dialysis: a forgotten risk factor. Medicine (Baltimore). 2015;94(20):e819.
Han JH, Han JS, Kim EJ, et al. Diastolic dysfunction is an independent predictor of cardiovascular events in incident dialysis patients with preserved systolic function. PLoS ONE. 2015;10(3):e0118694.
pubmed: 25739020
pmcid: 4349827
Pecoits-Filho R, Bucharles S, Barberato SH. Diastolic heart failure in dialysis patients: mechanisms, diagnostic approach, and treatment. Semin Dial. 2012;25(1):35–41.
pubmed: 22273530
Barberato SH, Bucharles SG, Sousa AM, et al. Prevalence and prognostic impact of diastolic dysfunction in patients with chronic kidney disease on hemodialysis. Arq Bras Cardiol. 2010;94(4):457–62.
pubmed: 20339814
de Bie MK, Ajmone Marsan N, Gaasbeek A, et al. Left ventricular diastolic dysfunction in dialysis patients assessed by novel speckle tracking strain rate analysis: prevalence and determinants. Int J Nephrol. 2012;2012:963504.
pubmed: 22649726
pmcid: 3357524
Rosello A, Torregrosa I, Solis MA, et al. Study of diastolic function in peritoneal dialysis patients. Comparison between pulsed doppler and tissue doppler. Nefrologia. 2007;27(4):482–8.
pubmed: 17944586
Kimura H, Takeda K, Tsuruya K, et al. Left ventricular mass index is an independent determinant of diastolic dysfunction in patients on chronic hemodialysis: a tissue doppler imaging study. Nephron Clin Pract. 2011;117(1):c67–c73.
pubmed: 20689327
Gunal AI, Ilkay E, Kirciman E, et al. Blood pressure control and left ventricular hypertrophy in long-term CAPD and hemodialysis patients: a cross-sectional study. Perit Dial Int. 2003;23(6):563–7.
pubmed: 14703197
Ellouali F, Berkchi F, Bayahia R, et al. Comparison of the effects of dialysis methods (haemodialysis vs peritoneal dialysis) on diastolic left ventricular function dialysis methods and diastolic function. Open Cardiovasc Med J. 2016;10:171–8.
pubmed: 27583042
pmcid: 4974827
Ahmadmehrabi S, Tang WHW. Hemodialysis-induced cardiovascular disease. Semin Dial. 2018;31(3):258–67.
pubmed: 29624739
pmcid: 6023623
Malyszko J. Mechanism of endothelial dysfunction in chronic kidney disease. Clin Chim Acta. 2010;411(19–20):1412–20.
pubmed: 20598675
Meyer C, Heiss C, Drexhage C, et al. Hemodialysis-induced release of hemoglobin limits nitric oxide bioavailability and impairs vascular function. J Am Coll Cardiol. 2010;55(5):454–9.
pubmed: 20117459
Gross ML, Ritz E. Hypertrophy and fibrosis in the cardiomyopathy of uremia–beyond coronary heart disease. Semin Dial. 2008;21(4):308–18.
pubmed: 18627569
Steeds RP, Wheeler R, Bhattacharyya S, et al. Stress echocardiography in coronary artery disease: a practical guideline from the British Society of Echocardiography. Echo Res Pract. 2019;6(2):G17–G33.
pubmed: 30921767
pmcid: 6477657
Sicari R, Nihoyannopoulos P, Evangelista A, et al. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr. 2008;9(4):415–37.
pubmed: 18579481
Dimitrow PP, Galderisi M, Rigo F. The non-invasive documentation of coronary microcirculation impairment: role of transthoracic echocardiography. Cardiovasc Ultrasound. 2005;3(18):1476–7120120.
Niizuma S, Takiuchi S, Okada S, et al. Decreased coronary flow reserve in haemodialysis patients. Nephrol Dial Transplant. 2008;23(7):2324–8.
pubmed: 18234846
Caliskan Y, Oflaz H, Demirturk M, et al. Coronary flow reserve dysfunction in hemodialysis and kidney transplant patients. Clin Transplant. 2008;22(6):785–93.
pubmed: 19040561
Tok D, Gullu H, Erdogan D, et al. Impaired coronary flow reserve in hemodialysis patients: a transthoracic Doppler echocardiographic study. Nephron Clin Pract. 2005;101(4):19.
Nakanishi K, Fukuda S, Shimada K, et al. Prognostic value of coronary flow reserve on long-term cardiovascular outcomes in patients with chronic kidney disease. Am J Cardiol. 2013;112(7):928–32.
pubmed: 23800551
Lakkas L, Naka KK, Bechlioulis A, et al. The prognostic role of myocardial strain indices and dipyridamole stress test in renal transplantation patients. Echocardiography. 2020;37(1):62–70.
pubmed: 31872917
Tona F, Silvestre C, Rigato M, et al. Coronary microvascular dysfunction predicts long-term outcome in simultaneous pancreas-kidney transplantation. Transplant Proc. 2016;48(2):344–8.
pubmed: 27109952
Papamichail N, Bechlioulis A, Lakkas L, et al. Impaired coronary microcirculation is associated with left ventricular diastolic dysfunction in end-stage chronic kidney disease patients. Echocardiography. 2020;00:1–10.
Bozbas H, Pirat B, Demirtas S, et al. Evaluation of coronary microvascular function in patients with end-stage renal disease, and renal allograft recipients. Atherosclerosis. 2009;202(2):498–504.
pubmed: 18550064
Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1–39 e14.
pubmed: 25559473
Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57(6):450–8.
pubmed: 2936235
Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2016;29(4):277–314.
pubmed: 27037982
Meimoun P, Tribouilloy C. Non-invasive assessment of coronary flow and coronary flow reserve by transthoracic Doppler echocardiography: a magic tool for the real world. Eur J Echocardiogr. 2008;9(4):449–57.
pubmed: 18296409
Simova I. Coronary flow velocity reserve assessment with transthoracic doppler echocardiography. Eur Cardiol. 2015;10(1):12–8.
pubmed: 30310417
pmcid: 6159450
Zoccali C, Benedetto FA, Mallamaci F, et al. Prognostic impact of the indexation of left ventricular mass in patients undergoing dialysis. J Am Soc Nephrol. 2001;12(12):2768–74.
pubmed: 11729247
Foley RN, Parfrey PS, Harnett JD, et al. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47(1):186–92.
pubmed: 7731145
Silberberg JS, Barre PE, Prichard SS, et al. Impact of left ventricular hypertrophy on survival in end-stage renal disease. Kidney Int. 1989;36(2):286–90.
pubmed: 2528654
Mitsnefes MM, Daniels SR, Schwartz SM, et al. Severe left ventricular hypertrophy in pediatric dialysis: prevalence and predictors. Pediatr Nephrol. 2000;14(10–11):898–902.
pubmed: 10975295
Tian JP, Wang T, Wang H, et al. The prevalence of left ventricular hypertrophy in Chinese hemodialysis patients is higher than that in peritoneal dialysis patients. Ren Fail. 2008;30(4):391–400.
pubmed: 18569912
Enia G, Mallamaci F, Benedetto FA, et al. Long-term CAPD patients are volume expanded and display more severe left ventricular hypertrophy than haemodialysis patients. Nephrol Dial Transplant. 2001;16(7):1459–64.
pubmed: 11427641
Lai S, Molfino A, Russo GE, et al. Cardiac, inflammatory and metabolic parameters: hemodialysis versus peritoneal dialysis. Cardiorenal Med. 2015;5(1):20–30.
pubmed: 25759697
Foley RN, Parfrey PS, Harnett JD, et al. Mode of dialysis therapy and mortality in end-stage renal disease. J Am Soc Nephrol. 1998;9(2):267–76.
pubmed: 9527403
Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol. 1999;10(7):1606–15.
pubmed: 10405218
Wang AY, Wang M, Lam CW, et al. Left ventricular filling pressure by Doppler echocardiography in patients with end-stage renal disease. Hypertension. 2008;52(1):107–14.
pubmed: 18474835
Kibel A, Selthofer-Relatic K, Drenjancevic I, et al. Coronary microvascular dysfunction in diabetes mellitus. J Int Med Res. 2017;45(6):1901–29.
pubmed: 28643578
pmcid: 5805190